157 related articles for article (PubMed ID: 36338430)
1. Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis.
Zhu X; Zhou H
J Hepatocell Carcinoma; 2022; 9():1127-1136. PubMed ID: 36338430
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects.
Zhu X; Song H; Chen Y; Han F; Wang Q; Cui Y
Dis Markers; 2020; 2020():8844698. PubMed ID: 33133306
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma.
Chen X; Mohammed AF; Li C
Clin Appl Thromb Hemost; 2024; 30():10760296231221535. PubMed ID: 38591958
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country.
Galun D; Bogdanovic A; Djokic Kovac J; Bulajic P; Loncar Z; Zuvela M
Cancer Manag Res; 2018; 10():977-988. PubMed ID: 29765248
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
Du Z; Dong J; Bi J; Bai R; Zhang J; Wu Z; Lv Y; Zhang X; Wu R
PLoS One; 2018; 13(4):e0195336. PubMed ID: 29621282
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
7. Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma.
Li SC; Xu Z; Deng YL; Wang YN; Jia YM
Medicine (Baltimore); 2020 Jul; 99(27):e20919. PubMed ID: 32629689
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma.
Lin Z; Li H; He C; Yang M; Chen H; Yang X; Zhuo J; Shen W; Hu Z; Pan L; Wei X; Lu D; Zheng S; Xu X
Front Oncol; 2023; 13():1072775. PubMed ID: 36845695
[TBL] [Abstract][Full Text] [Related]
9. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma.
Zhu W; Shi P; Liang A; Zhu Y; Fu J; Yuan S; Wu X
BMC Cancer; 2022 Oct; 22(1):1061. PubMed ID: 36241994
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization.
Liu C; Jia BS; Zou BW; Du H; Yan LN; Yang JY; Jiang L; Wen TF; Lu WS
Medicine (Baltimore); 2017 Nov; 96(45):e8512. PubMed ID: 29137051
[TBL] [Abstract][Full Text] [Related]
11. Platelet Distribution Width in Hepatocellular Carcinoma.
Guo F; Zhu X; Qin X
Med Sci Monit; 2018 Apr; 24():2518-2523. PubMed ID: 29689031
[TBL] [Abstract][Full Text] [Related]
12. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
13. The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy.
He C; Zhang Y; Cai Z; Lin X
Cancer Manag Res; 2019; 11():1391-1400. PubMed ID: 30863150
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure.
Chiriac S; Stanciu C; Singeap AM; Sfarti CV; Cuciureanu T; Trifan A
Turk J Gastroenterol; 2020 Dec; 31(12):868-876. PubMed ID: 33625999
[TBL] [Abstract][Full Text] [Related]
15. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.
Michalak A; Cichoż-Lach H; Guz M; Kozicka J; Cybulski M; Jeleniewicz W; Stepulak A
World J Gastroenterol; 2020 Dec; 26(47):7538-7549. PubMed ID: 33384553
[TBL] [Abstract][Full Text] [Related]
16. Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma.
Yasser MB; Abdellatif M; Emad E; Jafer A; Ahmed S; Nageb L; Abdelshafy H; Al-Anany AM; Al-Arab MAE; Gibriel AA
Virus Res; 2021 Apr; 296():198341. PubMed ID: 33607184
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of neutrophil-to-lymphocyte ratio at different time points in patients with hepatocellular carcinoma receiving liver resection.
Dai T; Lin G; Deng M; Zhu S; Li H; Yao J; Li H; Liu W; Yang Y; Chen G; Wang G
Transl Cancer Res; 2020 Feb; 9(2):441-457. PubMed ID: 35117389
[TBL] [Abstract][Full Text] [Related]
18. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
19. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
Chen Y; Yang Y; Zhang XY; Fan QS; Li X; Xin YJ; Cao XJ; Wang YN; Zhou X
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1551-1560. PubMed ID: 34036405
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
